Lis endorsement- Background Marketing remodeling - Jian-Min joint pain pills wind market marketing planning Documentary.docVIP

 PAGE \* MERGEFORMAT 10 Li’s endorsement: Background Marketing remodeling - Jian-Min joint pain pills wind market marketing planning Documentary The market is not optimistic In March 2003, when we talk with well-known pharmaceutical enterprises in China, Wuhan Jianmin Pharmaceutical Group, along with in-depth understanding of arthritis market, we still can not help but hardened to the size of the market shocked: Arthritis is the most common middle-aged refractory diseases. According to statistics, China’s 120 million people each year become disabled due to arthritis. Medicine, rheumatism, arthritis, known as the ‘number one disabling disease of mankind’, ‘die of cancer’, common in the elderly, with the average human life expectancy increases, the incidence of osteoarthritis are increasingly high, it is a serious impede the people’s work, becoming unable to work after the age of 50 the second most common cause, after heart disease. According to statistics, the incidence of osteoarthritis have a close relationship with age, age less than 45 years the incidence rate of 2% -3%; 45-64 years of age was 24.5% -30%, over 65 years of age up to 58% -- 68%, and the incidence of women than men. However, at present in many of the arthritis treatment drug among the western medicine is still the main, OTC market is only Fenbid, Voltaren few international brands such as active. As people get acquainted with traditional Chinese medicine, Chinese medicine treatment for arthritis patients are increasingly being adopted by some domestic pharmaceutical companies are launching off some of their own products, but the real scale and impact is very small. We are planning to take over the entire case of ‘Jian-Min Feng joint pain pill’ is a Group of Wuhan Jianmin Sinopharm fine tradition, but because of traditional marketing thinking and marketing costs of the limited constraints, the same was buried in many OTC products among Over the years, should not emit their own light. A high